Sleep Disorders Clinical Trials 2023

Browse 64 Sleep Disorders Medical Studies Across 110 Cities

5 Phase 3 Trial · 184 Sleep Disorders Clinics

Reviewed by Michael Gill, B. Sc.
10 Sleep Disorders Clinical Trials Near Me
Top Hospitals for Sleep Disorders Clinical Trials
Image of University of Virginia in Virginia.
University of Virginia
Charlottesville
2Active Trials
1All Time Trials for Sleep Disorders
2020First Sleep Disorders Trial
Image of Tom Baker Cancer Centre in Alberta.
Tom Baker Cancer Centre
Calgary
2Active Trials
0All Time Trials for Sleep Disorders
2009First Sleep Disorders Trial
Image of CancerCare Manitoba in Manitoba.
CancerCare Manitoba
Winnipeg
2Active Trials
0All Time Trials for Sleep Disorders
2009First Sleep Disorders Trial
Image of San Francisco VA Medical Center, San Francisco, CA in California.
San Francisco VA Medical Center, San Francisco, CA
San Francisco
2Active Trials
0All Time Trials for Sleep Disorders
2024First Sleep Disorders Trial
Image of M D Anderson Cancer Center in Texas.
M D Anderson Cancer Center
Houston
2Active Trials
0All Time Trials for Sleep Disorders
2023First Sleep Disorders Trial
Top Cities for Sleep Disorders Clinical Trials
Image of New York in New York.
New York
8Active Trials
Icahn School of Medicine at Mount SinaiTop Active Site
Image of Baltimore in Maryland.
Baltimore
6Active Trials
Man Alive Inc., Lane Treatment CenterTop Active Site
Sleep Disorders Clinical Trials by Phase of TrialSleep Disorders Clinical Trials by Age Group
< 18 Sleep Disorders Clinical Trials
5Active Sleep Disorders Clinical Trials
Most Recent Sleep Disorders Clinical TrialsTop Treatments for Sleep Disorders Clinical Trials
Treatment Name
Active Sleep Disorders Clinical Trials
All Time Trials for Sleep Disorders
First Recorded Sleep Disorders Trial
Suvorexant
2
2
2019
Home sleep apnea test
2
2
2022
Melatonin
2
2
2012
SHUTi OASIS
1
1
2023
Dupilumab
1
1
2023

What Are Sleep Disorder Clinical Trials?

Sleep disorders are an umbrella term for conditions that affect sleep quality, timing, or duration. When sleep is compromised for an extended period, the outcome can be detrimental to your health. Sleep disturbances are associated with psychological disorders, chronic conditions, and neurological problems.

Some patients suffering from sleep disorders have trouble falling or remaining asleep. However, others find it difficult to remain awake. Patients may also be prone to behaviors or conditions that disrupt their sleep quality.

Clinical trials for sleep disorders investigate chronic sleep disorders' physiological and psychological outcomes. Furthermore, trials aim to find new and effective treatment strategies to mitigate the development of secondary complications.

Why Are Sleep Disorders Being Studied Through Clinical Trials?

The amount of sleep required varies; however, most adults need a minimum of seven hours each night. However, epidemiology studies report that thirty percent of adults sleep less than six hours per night and more than fifty million Americans suffer from chronic sleep disorders.

Therefore, clinical trials are essential to addressing the threat that sleep disorders impose on global health. Researchers aim to discover more about the long-term outcomes of sleep disorders and more effective ways of improving sleep in patients suffering from these disorders.

What Are The Types of Treatments Available For Sleep Disorders?

Sleep specialists use polysomnograms to diagnose patients who experience sleep disturbances. Furthermore, patients are encouraged to keep a record of the quality and length of their sleep. Keeping a diary helps reveal sleeping patterns and identify factors contributing to poor sleep.

Encouraging good sleep hygiene is a conservative first-line approach to managing sleep disorders. Noise, light, temperature, exercise, and strict bedtimes are all factors that contribute to good sleep hygiene. Cognitive behavior therapy helps patients identify behaviorisms and thoughts that negatively impact their sleep.

Alternatively, drug therapies may be indicated in patients who struggle with disturbed sleep despite following conservative treatment routes. Some patients who struggle with sleep prefer natural agents, such as melatonin. However, in patients with severe insomnia, agents such as zolpidem may be more appropriate.

What Are Some Recent Breakthrough Clinical Trials For Sleep Disorders?

Researchers have made several significant discoveries about sleep disorders and the treatment thereof, such as the following:

2019: The five subtypes of insomnia: using personality types and brain activity, researchers at the Netherlands Institute for Neuroscience have identified five subtypes of insomnia. This classification system enables specialists to create individualized treatment plans for insomnia patients.

2021: The eXciteOSA® therapy for sleep apnea: The FDA recently approved a new therapy for sleep apnea. The eXciteOSA® improves the muscle function of the tongue through electrical stimulation, which assists in preventing airway collapse.

Who Are Some Of The Key Researchers Conducting Sleep Disorder Clinical Trial Research?

The OHSU is a world leader in sleep disorder research. Under the leadership of Dr. Asha Singh, the OHSU Sleep Medicine Program director, the university has made groundbreaking strides in new and effective ways of treating sleep disorders.

Under Dr. Clete Kushida, The Chief Of The Division And Medical Doctor Of Sleep Medicine, researchers at Stanford University are global leaders in sleep disorder research.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 1st, 2021

Last Reviewed: September 13th, 2023

References1 Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092. https://pubmed.ncbi.nlm.nih.gov/167171712 Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. https://pubmed.ncbi.nlm.nih.gov/167171713 Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. https://pubmed.ncbi.nlm.nih.gov/66684174 Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4. https://pubmed.ncbi.nlm.nih.gov/27487715 Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. https://pubmed.ncbi.nlm.nih.gov/27487716 Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063. https://pubmed.ncbi.nlm.nih.gov/33978657 Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57. https://pubmed.ncbi.nlm.nih.gov/98815388 Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. https://pubmed.ncbi.nlm.nih.gov/33978659 Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57. Review. https://pubmed.ncbi.nlm.nih.gov/988153810 Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. doi: 10.1016/s1389-9457(00)00065-4. https://pubmed.ncbi.nlm.nih.gov/11438246